Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPRIT
NCT00161070Phase 4Completed
- Start
- Jul 1997
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin and dipyridamole in Transient Ischemic Attack (TIA) and ischemic stroke (3 arms). Primary endpoint: Death from all vascular causes, nonfatal stroke, nonfatal myocardial infarction or major bleeding complication at 3 years. Started Jul 1997; status: completed.
02
Drugs
aspirindipyridamole
03
Conditions
Transient Ischemic Attack (TIA)ischemic stroke
Beyond the preview
Go deeper on NCT00161070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00161070.